ea0032p1017 | Thyroid (non-cancer) | ECE2013
Calan Mehmet
, Bilgir Oktay
, Bilgir Ferda
, Topcuoglu Tugba
, Calan Ozlem
Background: This study was planned to reveal the effect of propylthiouracil treatment on CD40, hs-CRP and Fetuin-A levels of subjects with subclinical hyperthyroidism.Material and methods: After checking CD40, hs-CRP and Fetuin-A levels of 35 patients with subclinical hyperthyroidism, they were given 50 mg of propylthiouracil tablet (thrice daily). After the 3-month administration, CD40, hs-CRP and Fetuin-A levels were then compared to the levels before ...